Synergy Asset Management LLC lessened its holdings in Globe Life Inc. (NYSE:GL - Free Report) by 92.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,617 shares of the company's stock after selling 92,986 shares during the quarter. Synergy Asset Management LLC's holdings in Globe Life were worth $1,065,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Kathmere Capital Management LLC lifted its stake in Globe Life by 6.6% during the 4th quarter. Kathmere Capital Management LLC now owns 2,361 shares of the company's stock valued at $330,000 after acquiring an additional 146 shares during the period. Czech National Bank boosted its holdings in shares of Globe Life by 2.0% in the 4th quarter. Czech National Bank now owns 20,991 shares of the company's stock valued at $2,936,000 after acquiring an additional 417 shares during the last quarter. DAVENPORT & Co LLC increased its stake in shares of Globe Life by 61.5% in the fourth quarter. DAVENPORT & Co LLC now owns 5,250 shares of the company's stock worth $734,000 after acquiring an additional 2,000 shares during the period. Salem Investment Counselors Inc. increased its stake in shares of Globe Life by 11.1% in the fourth quarter. Salem Investment Counselors Inc. now owns 6,000 shares of the company's stock worth $839,000 after acquiring an additional 600 shares during the period. Finally, SG Americas Securities LLC raised its holdings in shares of Globe Life by 909.6% during the fourth quarter. SG Americas Securities LLC now owns 99,746 shares of the company's stock worth $13,950,000 after purchasing an additional 89,866 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.
Globe Life Stock Up 0.9%
GL stock opened at $138.74 on Friday. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The firm's fifty day moving average is $141.52 and its 200 day moving average is $138.89. The firm has a market cap of $10.88 billion, a PE ratio of 9.85 and a beta of 0.46.
Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The firm had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.53 billion. During the same period in the previous year, the company earned $3.14 earnings per share. The company's revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, research analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.
Globe Life Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. This is an increase from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Thursday, April 2nd. Globe Life's dividend payout ratio (DPR) is currently 9.38%.
Analyst Ratings Changes
GL has been the subject of a number of research reports. TD Cowen restated a "buy" rating on shares of Globe Life in a research report on Thursday, December 11th. Texas Capital upgraded Globe Life to a "strong-buy" rating in a research note on Wednesday, March 18th. Wells Fargo & Company boosted their price objective on Globe Life from $170.00 to $171.00 and gave the company an "overweight" rating in a report on Wednesday, February 25th. Weiss Ratings upgraded Globe Life from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, February 13th. Finally, Keefe, Bruyette & Woods reaffirmed an "outperform" rating and set a $168.00 target price on shares of Globe Life in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $172.00.
Read Our Latest Research Report on Globe Life
Insider Activity at Globe Life
In other news, CEO Frank M. Svoboda sold 12,500 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the transaction, the chief executive officer owned 35,868 shares in the company, valued at $5,192,969.04. This trade represents a 25.84% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the completion of the sale, the chief marketing officer directly owned 17,479 shares in the company, valued at $2,501,944.06. This represents a 36.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 82,807 shares of company stock valued at $12,041,286 in the last ninety days. 1.51% of the stock is currently owned by company insiders.
Globe Life Profile
(
Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report